Center for Drug Evaluation and Research
View detailed information about Center for Drug Evaluation and Research, including compliance records, people, and regulatory data.
Comprehensive profile of Center for Drug Evaluation and Research, including its role, location, and regulatory activities.
Drugs • November 16, 2009
Drugs • September 8, 2010
Drugs • November 16, 2009
Drugs • September 19, 2017
Drugs • October 7, 2011
drugs • October 29, 2026
Drugs • February 11, 2013
Drugs • November 16, 2009
Drugs • January 24, 2013
BLA • December 17, 2021
BLA • January 17, 2019
NDA (New Drug Application) • March 10, 2025
Drugs • November 9, 2021
NDA (New Drug Application) • December 5, 2024
Drugs • July 18, 2014
Drugs • June 12, 2025
Drugs • August 19, 2019
Drugs • May 26, 2020
NDA (New Drug Application) • July 11, 2024
NDA (New Drug Application) • October 21, 2024
Showing 1 to 20 of 20 records
Name
Center for Drug Evaluation and Research
Abbreviation
CDER
Country
USA
Postal Code
20993
State/Province
Maryland
City
Maryland
Address
10001 New Hampshire Avenue, Hillandale Building
Office Website
Visit WebsiteID: cd980d74-1cbf-4226-ba9a-9045324c236c
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.